Trials / Completed
CompletedNCT00795054
The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family: A Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Center for International Blood and Marrow Transplant Research · Network
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.
Detailed description
Allogeneic hematopoietic stem cell transplantation (HSCT) is the indicated treatment for many life-threatening illnesses affecting both adults and children. Transplant recovery and late effects require long-term medical care. At the same time that the family faces a medical crisis, a resulting financial crisis may also be pending, but is often pushed to the background due to the necessity of first preserving life. A large proportion of patients undergoing HSCT incur significant financial burden from out-of-pocket costs and a decrease in household income. Predetermined variables, both medical and demographic, gathered at the pre-transplant clinical consultation have the potential to predict the patients at greatest financial risk. This study will describe both the out-of-pocket costs and the income changes that may result from HSCT to help patients and their caregivers have a clearer picture of these costs and develop a financial plan. Health care providers can utilize this information to better inform patients and connect them to resources.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Household financial data collection | Baseline financial survey pre-transplant, financial diary post-transplant every two weeks for 3 months, and financial questionnaire via phone survey at 6, 12, 18 and 24 months post-transplant. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2012-09-01
- Completion
- 2015-08-01
- First posted
- 2008-11-21
- Last updated
- 2015-10-06
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00795054. Inclusion in this directory is not an endorsement.